Sort
50,496 grants matching “lung cancer”
Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
$1,424,928Aaron Thomas Gerds · Case Western Reserve University · UG1 · FY2022 · CA
Biomarkers of Lung Cancer Susceptibility in Minorities
$1,424,277John K. Wiencke · University Of California, San Francisco · R01 · FY2006 · ES
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,423,817Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$1,423,746Rong Fan · Yale University · U01 · FY2020 · CA
Cytokines and T Cell Development
$1,423,160Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$1,422,960William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)
$1,422,383Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2019 · HL
UMDNJ/Rutgers University CounterACT Research Center of Excellence
$1,421,485Jeffrey D Laskin · Rbhs-Robert Wood Johnson Medical School · U54 · FY2016 · AR
DCTD Computer Support
$1,421,384David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Impact of Stretching on Tumor growth and Metastasis
$1,421,200Lisbeth Berrueta · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
$1,420,853Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R44 · FY2025 · CA
Mechanisms of transcriptional and replicative mutagenesis
$1,420,696Paul Doetsch · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,420,487Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2015 · CA
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,420,487Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2016 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,420,204Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Tobacco Carcinogenesis and Chemoprevention
$1,419,959Institute For Cancer Prevention · P01 · FY2003 · CA
Research Project 2
$1,419,459Chong-Xian Pan · University Of California At Davis · U54 · FY2018 · CA
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,418,999Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Late-stage development and de-risking of a novel monoclonal antibody immunotherapy for EGFR-positive solid cancers
$1,418,424Howard M Stern · Tigatx Inc · R44 · FY2024 · CA
Cancer Epidemiology Cohort in Male Health Professionals
$1,417,851Walter C. Willett · Harvard School Of Public Health · U01 · FY2023 · CA
Integrated analyses of genetics, epigenetics, and gene expression
$1,417,383Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2024 · CA
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$1,417,336Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2017 · AI
Impact of Stretching on Tumor growth and Metastasis
$1,417,327Lisbeth Berrueta Carrillo · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,414,272Lois B. Travis · University Of Rochester · R01 · FY2013 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$1,413,551William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA